![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 46, 36256-36262, November 17, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Division of Applied Toxicology, Institute of Toxicology,
University of Mainz, Obere Zahlbacher Strasse 67, D-55131 Mainz,
Germany
Mammalian mismatch repair has been implicated in
mismatch correction, the prevention of mutagenesis and cancer, and the
induction of genotoxicity and apoptosis. Here, we show that
treatment of cells specifically with agents inducing
O6-methylguanine in DNA, such as
N-methyl-N'-nitro-N-nitrosoguanidine and N-methyl-N-nitrosourea, elevates the level
of MSH2 and MSH6 and increases GT mismatch binding activity in
the nucleus. This inducible response occurs immediately after
alkylation, is long-lasting and dose-dependent, and results
from translocation of the preformed MutS
Nuclear Translocation of Mismatch Repair Proteins MSH2 and MSH6
as a Response of Cells to Alkylating Agents*
complex (composed of MSH2
and MSH6) from the cytoplasm into the nucleus. It is not caused by an
increase in MSH2 gene activity. Cells expressing the DNA repair protein
O6-methylguanine-DNA methyltransferase (MGMT), thus having
the ability to repair O6-methylguanine, showed no
translocation of MutS
, whereas inhibition of MGMT by
O6-benzylguanine provoked the translocation. The results
demonstrate that O6-methylguanine lesions are involved in
triggering nuclear accumulation of MSH2 and MSH6. The finding that
treatment of cells with O6-methylguanine-generating
mutagens results in an increase of MutS
and GT binding activity in
the nucleus indicates a novel type of genotoxic stress response.
*
This work was supported by the Deutsche
Forschungsgemeinschaft (SFB 519/B4).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
0049-6131-393-3246; Fax: 0049-6131-393-3421; E-mail:
Kaina@mail.uni-mainz.de.
This article has been cited by other articles:
![]() |
W.-J. Kim, B. Rajasekaran, and K. D. Brown MLH1- and ATM-dependent MAPK Signaling Is Activated through c-Abl in Response to the Alkylator N-Methyl-N'-nitro-N'-nitrosoguanidine J. Biol. Chem., November 2, 2007; 282(44): 32021 - 32031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christmann, M. T. Tomicic, D. Aasland, and B. Kaina A role for UV-light-induced c-Fos: stimulation of nucleotide excision repair and protection against sustained JNK activation and apoptosis Carcinogenesis, January 1, 2007; 28(1): 183 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christmann, M. T. Tomicic, J. Origer, D. Aasland, and B. Kaina c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the re-synthesis of XPF Nucleic Acids Res., December 2, 2006; 34(22): 6530 - 6539. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O'Brien and R. Brown Signalling cell cycle arrest and cell death through the MMR System Carcinogenesis, April 1, 2006; 27(4): 682 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Tomicic, M. Christmann, and B. Kaina Topotecan-Triggered Degradation of Topoisomerase I Is p53-Dependent and Impacts Cell Survival Cancer Res., October 1, 2005; 65(19): 8920 - 8926. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Humbert, I. Achour, D. Lautier, G. Laurent, and B. Salles hMSH2 expression is driven by AP1-dependent regulation through phorbol-ester exposure Nucleic Acids Res., October 1, 2003; 31(19): 5627 - 5634. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Berry, T. Loh, T. Yan, and T. J. Kinsella Role of MutS{alpha} in the Recognition of Iododeoxyuridine in DNA Cancer Res., September 1, 2003; 63(17): 5490 - 5495. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Petrin, A. Baker, S. G. Coupland, P. Liston, M. Narang, K. Damji, B. Leonard, V. A. Chiodo, A. Timmers, W. Hauswirth, et al. Structural and Functional Protection of Photoreceptors from MNU-Induced Retinal Degeneration by the X-Linked Inhibitor of Apoptosis Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2757 - 2763. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Wheeler, L.-A. Lebel, V. Vrbanac, A. Teed, H. te Riele, and M. E. MacDonald Mismatch repair gene Msh2 modifies the timing of early disease in HdhQ111 striatum Hum. Mol. Genet., February 1, 2003; 12(3): 273 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Bocangel, S. Finkelstein, S. C. Schold, K. K. Bhakat, S. Mitra, and D. M. Kokkinakis Multifaceted Resistance of Gliomas to Temozolomide Clin. Cancer Res., August 1, 2002; 8(8): 2725 - 2734. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Humbert, T. Hermine, H. Hernandez, T. Bouget, J. Selves, G. Laurent, B. Salles, and D. Lautier Implication of Protein Kinase C in the Regulation of DNA Mismatch Repair Protein Expression and Function J. Biol. Chem., May 10, 2002; 277(20): 18061 - 18068. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christmann, M. T. Tomicic, and B. Kaina Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutS{alpha} mismatch-binding activity Nucleic Acids Res., May 1, 2002; 30(9): 1959 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Richardson, L. B. Augustin, B. T. Kren, and C. J. Steer Gene Repair and Transposon-Mediated Gene Therapy Stem Cells, March 1, 2002; 20(2): 105 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Boldogh, D. Milligan, M. S. Lee, H. Bassett, R. S. Lloyd, and A. K. McCullough hMYH cell cycle-dependent expression, subcellular localization and association with replication foci: evidence suggesting replication-coupled repair of adenine:8-oxoguanine mispairs Nucleic Acids Res., July 1, 2001; 29(13): 2802 - 2809. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Kokkinakis, D. B. Bocangel, S. C. Schold, R. C. Moschel, and A. E. Pegg Thresholds of O6-Alkylguanine-DNA Alkyltransferase which Confer Significant Resistance of Human Glial Tumor Xenografts to Treatment with 1,3-Bis(2-chloroethyl)-1-nitrosourea or Temozolomide Clin. Cancer Res., February 1, 2001; 7(2): 421 - 428. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |